Dr. Shuhao Wen is a distinguished scientist entrepreneur who serves as the co-founder, chairman of the board, and executive director of XtalPi Inc. ("QuantumPharm", 2228.HK). With a wealth of accolades to his name, Dr. Wen has been recognized as an expert in the National Major Talent Project, and Team Leader of High-Caliber Talents in Shenzhen. In 2020, he was named one of Fortune’s 40 Business Elites Under 40 in China, and in 2021, he received the Shenzhen Patent Award. Most recently, in 2023, he was honored as one of the Top Ten Outstanding Young Entrepreneurs in Shenzhen.

As a quantum physicist with over 11 years of research experience in computational physics and quantum chemistry, Dr. Wen has published 36 papers with more than 2,800 citations. His academic journey includes postdoctoral education and research at prestigious institutions such as the University of Science and Technology of China, the Dalian Institute of Chemical Physics of the Chinese Academy of Sciences, the University of California at Riverside, and the Massachusetts Institute of Technology, where he currently serves as a member of the Visiting Committee for the Department of Chemistry. In 2015, Dr. Wen co-founded XtalPi with his colleagues on MIT campus.

Under Dr. Wen's leadership, XtalPi has secured over 700 million US dollars through multiple rounds of financing and established key partnerships with industry leaders like Pfizer and top research institutions. His innovative vision has fostered the incubation and collaboration of several groundbreaking startup projects, propelling them to successful ventures. In a historic achievement, XtalPi made its debut on the Hong Kong Stock Exchange's Main Board in June 2024, becoming the first company to list under the Exchange's Chapter 18C rules for specialized technology firms.